| Josephine Shafer, PHARMD | |
|
16124 Foster St, Stilwell, KS 66085-8417 | |
| (844) 237-3561 | |
| (844) 237-3562 |
| Full Name | Josephine Shafer |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 16124 Foster St, Stilwell, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740718436 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 1-13361 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Josephine Shafer, PHARMD 16124 Foster St, Stilwell, KS 66085-8417 Ph: (844) 237-3561 | Josephine Shafer, PHARMD 16124 Foster St, Stilwell, KS 66085-8417 Ph: (844) 237-3561 |
News Archive
Liver transplantation is a surgical procedure in which a liver (or part of a liver) is removed from a donor and placed into a recipient. Although some transplants use a portion of the liver of living donors, the vast majority of donors are deceased.
ChemoCentryx, Inc., today announced that GlaxoSmithKline (GSK) has exercised its option to obtain an exclusive license for further development and worldwide commercialization of the investigational medicine CCX354, a potent and selective inhibitor of CCR1, a chemokine receptor that drives the recruitment of inflammatory cells into the joints of patients with rheumatoid arthritis (RA).
Kaiser Health News staff writer Phil Galewitz, working in collaboration with The Washington Post, reports: "Florida is on course to spend $6 million to reach out to nearly 4 million uninsured people and help them sign up for coverage in the federal health law's online marketplace this fall.
Naurex Inc. today announced that the U.S. Food and Drug Administration has granted Fast Track designation to the investigation of GLYX-13, the company's rapid-acting antidepressant in Phase 2 clinical development, as adjunctive therapy in major depressive disorder.
› Verified 8 days ago
George Rishmany, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3693 W 179th Ter, Stilwell, KS 66085 Phone: 913-681-8166 |